Healthcare stories
Large companies may gain a way to move AI pilots into production, as the platform adds governance and audit controls for enterprise workflows.
The deal should help the European consultancy expand as demand grows for data analytics and AI advice across financial services and retail.
Backing will fund trials, regulatory work and prototype development as Zuuka targets US demand for home-based insulin delivery.
Frontline staff gain a device that merges recording and live communications, as Hytera targets public safety, retail and healthcare users.
Enterprise buyers are demanding proof of what AI agents do, as scrutiny rises over permissions, ownership and audit trails across organisations.
The tie-up gives UK public sector and finance customers a route to use AI on governed legacy records without losing auditability or control.
Financial services and other regulated firms gain local support to deploy Aryza software faster as Nucleo becomes its UK and Ireland partner.
The move signals Agiloft's push to tie contract AI to reliable data, with the former chief legal officer now steering product strategy.
Closer cooperation in artificial intelligence, health and defence follows Canada-Ireland talks as bilateral trade reached $6 billion last year.
Growth across Europe and the Middle East is increasing pressure on Tredence to turn AI trials into larger enterprise contracts.
Security teams are being pushed to track unsanctioned AI agents after AI-related questions in procurement rose more than 30% in nine months.
Small firms risk falling behind unless they adopt AI for practical gains, as SMEC AI says many are still confused by the technology.
Acquirers could cut months from post-deal IT integration, as the tie-up aims to let staff use applications on day one after closing.
The ranking reflects rising demand for AI services that can modernise legacy systems without disrupting operations in regulated industries.
The tie-up aims to help regulated firms move generative AI from pilots into production, while training 50,000 TCS staff on Claude.
Despite rising AI adoption, most firms are failing to turn it into enterprise-wide gains because governance and workforce readiness lag badly.
The move adds senior health-system governance as the Brisbane software group scales digital patient-journey tools across Australia and overseas.
Governance failures have forced most Australian enterprises to pull back customer-facing AI agents, even as spending plans and deployments keep rising.
Consumer patience is thinning, with Australian customers most likely to walk away when poor communications or clumsy data capture erode trust.
UK banks, defence contractors and telecoms groups are backing a homegrown AI model designed to run inside customers' own systems.